ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Tolerability Study of Drug to Treat Schizophrenia

ClinicalTrials.gov ID: NCT00044005

Public ClinicalTrials.gov record NCT00044005. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Dose-Blinded, Multicenter, 6-Month Study of Safety and Tolerability of 3 Dose Levels of SM-13496 (Lurasidone) in Patients With Schizophrenia

Study identification

NCT ID
NCT00044005
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
98 participants

Conditions and interventions

Conditions

Interventions

  • Lurasidone 20 mg Drug
  • Lurasidone 40 mg Drug
  • Lurasidone 80mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2002
Primary completion
Oct 31, 2003
Completion
Oct 31, 2003
Last update posted
Apr 16, 2014

2002 – 2003

United States locations

U.S. sites
26
U.S. states
12
U.S. cities
24
Facility City State ZIP Site status
Birmingham Psychiatry Pharmaceutical Birmingham Alabama 35209
Institute for Psychopharmacology Research Cerritos California 90703
CNS Network Garden Grove California 92845
California Clinical Trials Medical Group Glendale California 91206
Optimum Health Services La Mesa California 91942
University of California, Irvine Orange California 92868
California Neuropsychopharmacology Clinical Research Institute San Diego California 92126
Psychiatric Institute of Washington Washington D.C. District of Columbia 20016
Comprehensive Neuroscience. Inc. Melbourne Florida 32935
Segal Institute for Clinical Research North Miami Florida 33161
University of South Florida Tampa Florida 33613
Coordinated Research of Florida, Inc Winter Park Florida 32789
Hawaii Research Center Honolulu Hawaii 96826
Alexian Brothers Behavioral Health Hospital Hoffman Estates Illinois 60194
American Medical Research Oak Brook Illinois 60523
Lake Mead Hospital North Las Vegas Nevada 89030
Comprehensive Clinical Research, CNS Clementon New Jersey 08021
ClinSearch, Inc. Kenilworth New Jersey 07033
Quantum Clinical Services Group Philadelphia Pennsylvania 19139
Albert Einstein Medical Center Philadelphia Pennsylvania 19141
Community Clinical Research Austin Texas 78756
FutureSearch Trials Austin Texas 78756
Claghorn Lesem Research Clinic, Inc. Bellaire Texas 77401
St. Paul Medical Center Dallas Texas 75235
CNS, Inc. Falls Church Virginia 22041
Medstream, Inc. Milwaukee Wisconsin 53210

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00044005, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2014 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00044005 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →